Immunovant (IMVT) Cash from Operations (2019 - 2026)
Immunovant's Cash from Operations was -$124.41 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$117.41 million a year earlier.
Powered by 
Analysis
Immunovant (IMVT) Cash from Operations (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immunovant's Cash from Operations was -$414.3 million through Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it was -$407.31 million.
- In earlier fiscal years, Cash from Operations was -$375.87 million in FY2025, -$214.23 million in FY2024, -$188.19 million in FY2023 and -$106.11 million in FY2022.
- The fiscal Q1 2027 figure marks the lowest quarterly Cash from Operations in data going back to fiscal Q4 2019.
- Per Business Quant data, IMVT's Cash from Operations in the three fiscal quarters before Q1 2027 was -$95.06 million (Q4 2026), -$92.33 million (Q3 2026) and -$102.52 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.52 Bn | 1,100.11 Bn | 19.71 Bn | 10.69 Bn |
| 2 | Johnson & Johnson | 616.33 Bn | 534.86 Bn | 17.26 Bn | 8.62 Bn |
| 3 | AbbVie | 500.08 Bn | 473.19 Bn | 12.70 Bn | 3.44 Bn |
| 4 | Merck | 366.80 Bn | 321.17 Bn | 12.21 Bn | 5.37 Bn |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn | 5.88 Bn |
| 6 | Astrazeneca | 261.59 Bn | 235.28 Bn | 12.86 Bn | 2.87 Bn |
| 7 | Amgen | 234.86 Bn | 190.26 Bn | 7.24 Bn | 4.00 Bn |
| 8 | Gilead Sciences | 189.95 Bn | 164.15 Bn | 6.22 Bn | 3.57 Bn |
| 9 | Pfizer | 169.63 Bn | 116.28 Bn | 10.94 Bn | 835.00 Mn |
| 10 | Immunovant | 5.81 Bn | 2.60 Bn | - | -124.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -124.41 Mn |
| Mar 31, 2026 | -95.06 Mn |
| Dec 31, 2025 | -92.33 Mn |
| Sep 30, 2025 | -102.52 Mn |
| Jun 30, 2025 | -117.41 Mn |
| Mar 31, 2025 | -110.64 Mn |
| Dec 31, 2024 | -100.39 Mn |
| Sep 30, 2024 | -88.65 Mn |
| Jun 30, 2024 | -76.20 Mn |
| Mar 31, 2024 | -59.70 Mn |
| Dec 31, 2023 | -47.10 Mn |
| Sep 30, 2023 | -60.06 Mn |
| Jun 30, 2023 | -47.37 Mn |
| Mar 31, 2023 | -55.79 Mn |
| Dec 31, 2022 | -46.40 Mn |
| Sep 30, 2022 | -20.19 Mn |
| Jun 30, 2022 | -65.82 Mn |
| Mar 31, 2022 | -32.96 Mn |
| Dec 31, 2021 | -31.90 Mn |
| Sep 30, 2021 | -20.05 Mn |
API Access
Immunovant Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();